Legend Strategy Completes Auro Hong Kong Acquisition, Gains Beisheng Stake

MT Newswires Live

03/06

Legend Strategy International (HKG:1355) said it completed its acquisition of Auro Hong Kong, giving it an indirect 37.5% equity interest in Beisheng Biotechnology, according to a Friday Hong Kong bourse filing.

The deal stems from a sale and purchase agreement signed in December 2025, under which Legend Strategy agreed to acquire 100% of Auro Hong Kong and a related shareholder loan for HK$22 million.

Auro Hong Kong's principal asset is its 37.5% stake in Beisheng Biotechnology, a Shenzhen-based synthetic biology infrastructure provider specializing in strain design and fermentation process development.

Legend Strategy said the acquisition could improve research and development efficiency and reduce costs for its healthcare and beauty business.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2617685785"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2617685785\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2617685785?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-06 17:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2617685785","market":"sh","top_or_hot":-1,"title":"Legend Strategy Completes Auro Hong Kong Acquisition, Gains Beisheng Stake","media":"MT Newswires Live","content":"<html><body><p> Legend <a href=\"https://laohu8.com/S/MSTR\">Strategy</a> International (HKG:1355) said it completed its acquisition of Auro Hong Kong, giving it an indirect 37.5% equity interest in Beisheng Biotechnology, according to a Friday Hong Kong bourse filing.</p><p>The deal stems from a sale and purchase agreement signed in December 2025, under which Legend <a href=\"https://laohu8.com/S/STRF\">Strategy</a> agreed to acquire 100% of Auro Hong Kong and a related shareholder loan for HK$22 million.</p><p>Auro Hong Kong's principal asset is its 37.5% stake in Beisheng Biotechnology, a Shenzhen-based synthetic biology infrastructure provider specializing in strain design and fermentation process development.</p><p>Legend Strategy said the acquisition could improve research and development efficiency and reduce costs for its healthcare and beauty business.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Legend Strategy Completes Auro Hong Kong Acquisition, Gains Beisheng Stake</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLegend Strategy Completes Auro Hong Kong Acquisition, Gains Beisheng Stake\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2026-03-06 17:15</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> Legend <a href=\"https://laohu8.com/S/MSTR\">Strategy</a> International (HKG:1355) said it completed its acquisition of Auro Hong Kong, giving it an indirect 37.5% equity interest in Beisheng Biotechnology, according to a Friday Hong Kong bourse filing.</p><p>The deal stems from a sale and purchase agreement signed in December 2025, under which Legend <a href=\"https://laohu8.com/S/STRF\">Strategy</a> agreed to acquire 100% of Auro Hong Kong and a related shareholder loan for HK$22 million.</p><p>Auro Hong Kong's principal asset is its 37.5% stake in Beisheng Biotechnology, a Shenzhen-based synthetic biology infrastructure provider specializing in strain design and fermentation process development.</p><p>Legend Strategy said the acquisition could improve research and development efficiency and reduce costs for its healthcare and beauty business.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4516","symbol_name":"特朗普概念","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2617685785","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2617685785","pubTimestamp":1772788507,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Legend Strategy International  said it completed its acquisition of Auro Hong Kong, giving it an indirect 37.5% equity interest in Beisheng Biotechnology, according to a Friday Hong Kong bourse filing.The deal stems from a sale and purchase agreement signed in December 2025, under which Legend Strategy agreed to acquire 100% of Auro Hong Kong and a related shareholder loan for HK$22 million.Auro Hong Kong's principal asset is its 37.5% stake in Beisheng Biotechnology, a Shenzhen-based synthetic biology infrastructure provider specializing in strain design and fermentation process development.Legend Strategy said the acquisition could improve research and development efficiency and reduce costs for its healthcare and beauty business.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4516":"特朗普概念","MSTK":"Tuttle Capital MSTR 0DTE Covered Call ETF","MSDD":"2倍做空MSTR ETF-GraniteShares","MSTP":"2倍做多MSTR ETF-GraniteShares","BK4596":"哈里斯概念","BK1164":"酒店、度假村与豪华游轮","09399":"南方两倍做空MSTR-U","01355":"朸浚国际","MSOO":"2倍上限加速MSTR ETF-Leverage Shares","BK4588":"碎股","3SMI.UK":"GRANITESHARES 3X SHORT MSTR DAILY ETP","BK4600":"加密货币概念","SMI3.UK":"GRANITESHARES 3X SHORT MSTR DAILY ETP","07399":"南方两倍做空MSTR","MTYY":"GraniteShares YieldBOOST MSTR ETF","BK4595":"比特币概念","MSTW":"Roundhill MSTR WeeklyPay ETF","3LMI.UK":"GRANITESHARES 3X LONG MSTR DAILY ETP","MSTX":"2倍做多MSTR ETF-Defiance","BK4023":"应用软件","07799":"南方两倍做多MSTR","WNTR":"做空MSTR期权收益策略ETF-YieldMax","APED":"STKd 100% MSTR & 100% COIN ETF","LMI3.UK":"GRANITESHARES 3X LONG MSTR DAILY ETP","MSTY":"MSTR期权收益策略ETF-YieldMax","MSST":"YieldMax MSTR Performance & Distribution Target 25 ETF","MSTZ":"2倍做空MSTR ETF-T-Rex","IMST":"MSTR期权收益策略ETF-Bitwise","BK4585":"ETF&股票定投概念","MST":"做多杠杆+收益MSTR ETF-Defiance","09799":"南方两倍做多MSTR-U","SMST":"2倍做空MSTR ETF-Defiance","MSTY.UK":"YIELDMAX MSTR OPTION INCOME STRATEGY ETC","MSII":"REX MSTR Growth & Income ETF"},"translate_title":"联想战略完成奥诺香港收购，获得北盛股份","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MSTP":0.6,"3LMI.UK":0.6,"07399":0.6,"MSTX":0.6,"MSDD":0.6,"09799":0.6,"MSST":0.6,"LMI3.UK":0.6,"MSII":0.6,"SMST":0.6,"MSTY.UK":0.6,"07799":0.6,"WNTR":0.6,"09399":0.6,"IMST":0.6,"01355":1.96,"MST":0.6,"MTYY":0.6,"APED":0.6,"MSOO":0.6,"3SMI.UK":0.6,"SMI3.UK":0.6,"MSTK":0.6,"MSTW":0.6,"MSTY":0.6,"MSTZ":0.6},"content_text":"Legend Strategy International (HKG:1355) said it completed its acquisition of Auro Hong Kong, giving it an indirect 37.5% equity interest in Beisheng Biotechnology, according to a Friday Hong Kong bourse filing.The deal stems from a sale and purchase agreement signed in December 2025, under which Legend Strategy agreed to acquire 100% of Auro Hong Kong and a related shareholder loan for HK$22 million.Auro Hong Kong's principal asset is its 37.5% stake in Beisheng Biotechnology, a Shenzhen-based synthetic biology infrastructure provider specializing in strain design and fermentation process development.Legend Strategy said the acquisition could improve research and development efficiency and reduce costs for its healthcare and beauty business.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}